Loading clinical trials...
Loading clinical trials...
Immediate Implant Placement With Provisionalization Using Autogenous Bone Graft Particulates vs Deproteinized Bovine Bone vs Nano-hydroxyapatite Alloplast as a Space Filling Material in the Maxillary Esthetic Zone
compare autogenous bone graft, xenograft and nanohydroxyapatite in immediate implant w placement in maxillary esthetic zone with provisionalization
Placement of implants into extraction sockets targets the maintenance of peri implant hard and soft tissue structures and the support of a natural and esthetic contour. The main advantages of immediate implant insertion in comparison with delayed implant placement protocols are as follows: a reduced treatment time, less number of sessions, and, thus, the less invasive procedure. This study examines the clinical performance (survival rate, marginal bone levels and Pink Esthetic Score \[PES\]) of OsseoSpeed™ implants placed into extraction sockets with immediate provisionalization in the anterior maxilla after a follow-up of at least 12 months. The removal of teeth results inevitably in both horizontal and vertical changes of hard and soft tissue dimensions. Clinical research has shown that the loss of volume in the extraction sockets is high: the biggest bone volumetric changes take place during the first 12 months from the dental extraction, with a reduction of bone volume of 50%, of which 2/3 (30%) are within the first 3 months. Nowadays to get success in postextraction implantology means managing the early and irreversible alveolar bone dimensional changes following tooth extraction, in order to minimize the negative effects on the aesthetics final.
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
Yes
Cairo University
Cairo, Egypt
Mohamed tarek
Cairo, Egypt
Start Date
November 27, 2018
Primary Completion Date
July 27, 2019
Completion Date
August 17, 2019
Last Updated
November 19, 2018
30
ESTIMATED participants
Autogenous bone graft as space filling in immidiate implant placment
PROCEDURE
Deprotinized bovien as space filling in immidate implant placement
PROCEDURE
Nano-hydroxiapatite alloplast in immidiate implant placement
PROCEDURE
Lead Sponsor
Mohamed tarek mohamed youssif omar
Collaborators
NCT07433920
NCT06099717
NCT06570499
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions